Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daisuke Kanai

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|December 31, 2024
Proteomic serum profiles before and after lipoprotein apheresis in patients with peripheral artery disease with ulcerationKohei Ishiga, Tatsuki Uehara, Hiromichi Wakui, et al.
Clinical and Experimental Nephrology|June 25, 2022
SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in JapanDaisuke Kanai, Hiromichi Wakui, Tatsuya Haze, et al.
Clinical and Experimental Nephrology|March 28, 2023
Blunted humoral immune response to the fourth dose of BNT162b2 COVID-19 vaccine in patients undergoing hemodialysisDaisuke Kanai, Hiromichi Wakui, Masaaki Hanaoka, et al.
Internal Medicine (Tokyo, Japan)|September 29, 2024
Clinical Course and Factors Correlated with Severe Morbidity and Mortality in Patients with Coronavirus Disease 2019 Undergoing Maintenance Dialysis in Kanagawa, JapanKohei Ishiga, Hiromichi Wakui, Kengo Azushima, et al.
BMC Nephrology|September 27, 2025
Effects of sodium zirconium cyclosilicate on the quality of life of patients with hyperkalemia undergoing hemodialysis: Y-QOL study designShiori Yoshimura, Daisuke Kanai, Hiromichi Wakui, et al.
Modern Rheumatology|December 16, 2021
Effectiveness and safety of subcutaneous abatacept in biologic-naïve RA patients at Week 52: A Japanese multicentre investigational study (ORIGAMI study)Naoto Tamura, Takanori Azuma, Kenta Misaki, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|December 31, 2024
Proteomic serum profiles before and after lipoprotein apheresis in patients with peripheral artery disease with ulcerationKohei Ishiga, Tatsuki Uehara, Hiromichi Wakui, et al.
Clinical and Experimental Nephrology|June 25, 2022
SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in JapanDaisuke Kanai, Hiromichi Wakui, Tatsuya Haze, et al.
Clinical and Experimental Nephrology|March 28, 2023
Blunted humoral immune response to the fourth dose of BNT162b2 COVID-19 vaccine in patients undergoing hemodialysisDaisuke Kanai, Hiromichi Wakui, Masaaki Hanaoka, et al.
Internal Medicine (Tokyo, Japan)|September 29, 2024
Clinical Course and Factors Correlated with Severe Morbidity and Mortality in Patients with Coronavirus Disease 2019 Undergoing Maintenance Dialysis in Kanagawa, JapanKohei Ishiga, Hiromichi Wakui, Kengo Azushima, et al.
BMC Nephrology|September 27, 2025
Effects of sodium zirconium cyclosilicate on the quality of life of patients with hyperkalemia undergoing hemodialysis: Y-QOL study designShiori Yoshimura, Daisuke Kanai, Hiromichi Wakui, et al.
Modern Rheumatology|December 16, 2021
Effectiveness and safety of subcutaneous abatacept in biologic-naïve RA patients at Week 52: A Japanese multicentre investigational study (ORIGAMI study)Naoto Tamura, Takanori Azuma, Kenta Misaki, et al.
Pageof 2